CD4 and kidney cancer: Similarly, the proportion of CD3+ (Extended Data Fig. 4a), CD4+ (Extended Data Fig. 4b), and CD8+ T cells (Extended Data Fig. 4c) was lower in kidney cancer inoculated on AA-treated kidneys than that on PBS treated kidneys.